A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients - ZAP2.
Dawn AitkenLaura L LaslettGuoqi CaiCatherine HillLyn MarchAnita E WlukaYuanyuan WangLeigh BlizzardFlavia CicuttiniGraeme JonesPublished in: BMC musculoskeletal disorders (2018)
Australian New Zealand Clinical Trials Registry: ACTRN12613000039785 , registered on 14 January 2013.